Tetrahydropyridopyrimidine pan-KRas inhibitors
US12421253B2 · kind B2 · utility
0Cited by
6References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2024 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Apr 24, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that inhibit at least one of KRas wild type, KRas G12A, KRas G12C, KRas G12D, KRas G12R, KRas G12S, KRas G12V, KRas G13D and KRas Q61H, pharmaceutical compositions comprising the compounds and methods of use therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.